Cargando…
SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients
Pseudomonas aeruginosa is the primary cause of chronic airway infections in cystic fibrosis (CF) patients. Persistent infections are seen from the first P. aeruginosa culture in about 75% of young CF patients, and it is important to discover new ways to detect P. aeruginosa at an earlier stage. The...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368648/ https://www.ncbi.nlm.nih.gov/pubmed/28349938 http://dx.doi.org/10.1038/srep45264 |
_version_ | 1782517966681669632 |
---|---|
author | Lauridsen, Rikke Kragh Sommer, Lea M. Johansen, Helle Krogh Rindzevicius, Tomas Molin, Søren Jelsbak, Lars Engelsen, Søren Balling Boisen, Anja |
author_facet | Lauridsen, Rikke Kragh Sommer, Lea M. Johansen, Helle Krogh Rindzevicius, Tomas Molin, Søren Jelsbak, Lars Engelsen, Søren Balling Boisen, Anja |
author_sort | Lauridsen, Rikke Kragh |
collection | PubMed |
description | Pseudomonas aeruginosa is the primary cause of chronic airway infections in cystic fibrosis (CF) patients. Persistent infections are seen from the first P. aeruginosa culture in about 75% of young CF patients, and it is important to discover new ways to detect P. aeruginosa at an earlier stage. The P. aeruginosa biomarker hydrogen cyanide (HCN) contains a triple bond, which is utilized in this study because of the resulting characteristic C≡N peak at 2135 cm(−1) in a Raman spectrum. The Raman signal was enhanced by surface-enhanced Raman spectroscopy (SERS) on a Au-coated SERS substrate. After long-term infection, a mutation in the patho-adaptive lasR gene can alter the expression of HCN, which is why it is sometimes not possible to detect HCN in the breath of chronically infected patients. Four P. aeruginosa reference strains and 12 clinical P. aeruginosa strains isolated from CF children were evaluated, and HCN was clearly detected from overnight cultures of all wild type-like isolates and half of the later isolates from the same patients. The clinical impact could be that P. aeruginosa infections could be detected at an earlier stage, because daily breath sampling with an immediate output could be possible with a point-of-care SERS device. |
format | Online Article Text |
id | pubmed-5368648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-53686482017-03-30 SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients Lauridsen, Rikke Kragh Sommer, Lea M. Johansen, Helle Krogh Rindzevicius, Tomas Molin, Søren Jelsbak, Lars Engelsen, Søren Balling Boisen, Anja Sci Rep Article Pseudomonas aeruginosa is the primary cause of chronic airway infections in cystic fibrosis (CF) patients. Persistent infections are seen from the first P. aeruginosa culture in about 75% of young CF patients, and it is important to discover new ways to detect P. aeruginosa at an earlier stage. The P. aeruginosa biomarker hydrogen cyanide (HCN) contains a triple bond, which is utilized in this study because of the resulting characteristic C≡N peak at 2135 cm(−1) in a Raman spectrum. The Raman signal was enhanced by surface-enhanced Raman spectroscopy (SERS) on a Au-coated SERS substrate. After long-term infection, a mutation in the patho-adaptive lasR gene can alter the expression of HCN, which is why it is sometimes not possible to detect HCN in the breath of chronically infected patients. Four P. aeruginosa reference strains and 12 clinical P. aeruginosa strains isolated from CF children were evaluated, and HCN was clearly detected from overnight cultures of all wild type-like isolates and half of the later isolates from the same patients. The clinical impact could be that P. aeruginosa infections could be detected at an earlier stage, because daily breath sampling with an immediate output could be possible with a point-of-care SERS device. Nature Publishing Group 2017-03-28 /pmc/articles/PMC5368648/ /pubmed/28349938 http://dx.doi.org/10.1038/srep45264 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Lauridsen, Rikke Kragh Sommer, Lea M. Johansen, Helle Krogh Rindzevicius, Tomas Molin, Søren Jelsbak, Lars Engelsen, Søren Balling Boisen, Anja SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients |
title | SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients |
title_full | SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients |
title_fullStr | SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients |
title_full_unstemmed | SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients |
title_short | SERS detection of the biomarker hydrogen cyanide from Pseudomonas aeruginosa cultures isolated from cystic fibrosis patients |
title_sort | sers detection of the biomarker hydrogen cyanide from pseudomonas aeruginosa cultures isolated from cystic fibrosis patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368648/ https://www.ncbi.nlm.nih.gov/pubmed/28349938 http://dx.doi.org/10.1038/srep45264 |
work_keys_str_mv | AT lauridsenrikkekragh sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients AT sommerleam sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients AT johansenhellekrogh sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients AT rindzeviciustomas sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients AT molinsøren sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients AT jelsbaklars sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients AT engelsensørenballing sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients AT boisenanja sersdetectionofthebiomarkerhydrogencyanidefrompseudomonasaeruginosaculturesisolatedfromcysticfibrosispatients |